View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsJubilant Industries 배당 및 자사주 매입배당 기준 점검 0/6Jubilant Industries 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률0.0001%자사주 매입 수익률총 주주 수익률0.0001%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공고 • Oct 03Jubilant Industries Limited Announces Resignation of Brijesh Kumar as Company Secretary & Compliance Officer, Effective November 13, 2024Jubilant Industries Limited announced that the Mr. Brijesh Kumar, Company Secretary & Compliance Officer of the Company has submitted resignation to pursue opportunity outside the organisation. The management has accepted his resignation and accordingly he shall be relieved from his responsibilities on November 13, 2024. Further, Mr. Brijesh Kumar has also tendered his resignation from the post of Company Secretary from wholly owned subsidiary of the Company Jubilant Agri and Consumer Products Limited November 13, 2024. The management has accepted his resignation and accordingly he shall be relieved from his responsibilities w.e.f November 13, 2024.공고 • Aug 30Jubilant Industries Limited, Annual General Meeting, Sep 23, 2024Jubilant Industries Limited, Annual General Meeting, Sep 23, 2024, at 15:00 Indian Standard Time.공고 • Aug 29+ 2 more updatesJubilant Industries Limited to Report Fiscal Year 2025 Results on May 15, 2025Jubilant Industries Limited announced that they will report fiscal year 2025 results on May 15, 2025Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: ₹17.31 (vs ₹13.84 in 1Q 2024)First quarter 2025 results: EPS: ₹17.31 (up from ₹13.84 in 1Q 2024). Revenue: ₹3.59b (up 3.0% from 1Q 2024). Net income: ₹260.8m (up 25% from 1Q 2024). Profit margin: 7.3% (up from 6.0% in 1Q 2024). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 42% per year, which means it is tracking significantly ahead of earnings growth.공고 • Aug 01Jubilant Industries Limited to Report Q1, 2025 Results on Aug 12, 2024Jubilant Industries Limited announced that they will report Q1, 2025 results on Aug 12, 2024Buy Or Sell Opportunity • Jul 05Now 20% undervaluedOver the last 90 days, the stock has risen 23% to ₹1,592. The fair value is estimated to be ₹1,998, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Meanwhile, the company has become profitable.공고 • Jun 27Jubilant Industries Limited and Jubilant Agri and Consumer Products Limited Announces Resignation of Jagat Sharma from the Post of Director and Whole Time DirectorJubilant Industries Limited at its board meeting held on June 27, 2024 Noted the resignation of Mr. Jagat Sharma from the post of Director and Whole Time Director of the Company with effect from the close of business hours on June 26, 2024, citing personal reasons. However, he will continue in the employment of the Company. Mr. Sharma has also resigned as Director and Whole Time Director of Jubilant Agri and Consumer Products Limited ("Wholly Owned Subsidiary" of the Company) with effect from the close of business hours on June 26, 2024. However, he will continue as an employee of JACPL.Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹1,286, the stock trades at a trailing P/E ratio of 66.1x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 310% over the past three years.Reported Earnings • May 29Full year 2024 earnings released: EPS: ₹19.37 (vs ₹35.06 in FY 2023)Full year 2024 results: EPS: ₹19.37 (down from ₹35.06 in FY 2023). Revenue: ₹12.5b (down 15% from FY 2023). Net income: ₹292.0m (down 45% from FY 2023). Profit margin: 2.3% (down from 3.6% in FY 2023). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 59% per year, which means it is tracking significantly ahead of earnings growth.공고 • May 17Jubilant Industries Limited to Report Q4, 2024 Results on May 27, 2024Jubilant Industries Limited announced that they will report Q4, 2024 results on May 27, 2024Buy Or Sell Opportunity • May 16Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 19% to ₹1,110. The fair value is estimated to be ₹917, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 32%.Board Change • Apr 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Sanjanthi Sajan was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Buy Or Sell Opportunity • Feb 21Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 64% to ₹1,122. The fair value is estimated to be ₹931, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 32%.공고 • Feb 19Jubilant Industries Limited Appoints Jagat Sharma as A Whole-Time DirectorJubilant Industries Limited appointed Jagat Sharma as a Whole-time Director.New Risk • Feb 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (73% net debt to equity). Share price has been volatile over the past 3 months (8.6% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin).New Risk • Feb 13New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 65% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (64% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin).Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹722, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 230% over the past three years.공고 • Jan 30Jubilant Industries Limited to Report Q3, 2024 Results on Feb 09, 2024Jubilant Industries Limited announced that they will report Q3, 2024 results on Feb 09, 2024Reported Earnings • Nov 07Second quarter 2024 earnings released: EPS: ₹6.00 (vs ₹9.75 in 2Q 2023)Second quarter 2024 results: EPS: ₹6.00 (down from ₹9.75 in 2Q 2023). Revenue: ₹3.12b (down 27% from 2Q 2023). Net income: ₹90.4m (down 39% from 2Q 2023). Profit margin: 2.9% (down from 3.4% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 47% per year whereas the company’s share price has increased by 49% per year.New Risk • Nov 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.5% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (7.6% average weekly change).New Risk • Oct 30New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.29b (US$99.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.5% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (₹8.29b market cap, or US$99.6m).공고 • Oct 28Jubilant Industries Limited to Report Q2, 2024 Results on Nov 06, 2023Jubilant Industries Limited announced that they will report Q2, 2024 results on Nov 06, 2023Board Change • Oct 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Ravinder Sharma was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공고 • Aug 27Jubilant Industries Limited, Annual General Meeting, Sep 21, 2023Jubilant Industries Limited, Annual General Meeting, Sep 21, 2023, at 15:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Aug 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹625, the stock trades at a trailing P/E ratio of 18.2x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 280% over the past three years.공고 • Aug 08Jubilant Industries Limited Appoints Brijesh Kumar as Company Secretary and Compliance OfficerThe Board of Directors of Jubilant Industries Limited at its meeting held on August 7, 2023 at 3:00 P.M. (concluded at 5:00 P.M.), had on the recommendations of the Nomination Remuneration and Compensation Committee approved the appointment of Mr. Brijesh Kumar as the Company Secretary and Compliance Officer of the company with immediate effect. Consequent to the said appointment, Mr. Abhishek Kamra (ICSI Membership No.: A48236) who was appointed on interim basis, will step down from the position of Company Secretary and Compliance Officer of the Company with immediate effect. Date of Appointment and Terms of Appointment: Date of Appointment is August 7, 2023 and terms of appointment shall be as per the companies HR Policy. Brief Profile: Mr. Brijesh Kumar is a member of the Institute of Company Secretaries of India, a graduate in Law and holds Bachelor's degree in Commerce - B.Com (Hons) with over 11 years of experience in the area of corporate secretarial and legal affairs of the Company. He has good experience in Securities and Capital Market Laws, Corporate Laws, FEMA and Compliance Management and has handled Merger and Acquisitions, Listing of shares, Fund Raising, ESOP, joint ventures etc. He was previously associated with Uno Minda Limited and AKM Global in the past.Reported Earnings • Aug 08First quarter 2024 earnings released: EPS: ₹13.84 (vs ₹14.43 in 1Q 2023)First quarter 2024 results: EPS: ₹13.84 (down from ₹14.43 in 1Q 2023). Revenue: ₹3.49b (down 1.6% from 1Q 2023). Net income: ₹208.6m (down 3.9% from 1Q 2023). Profit margin: 6.0% (down from 6.1% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 58% per year whereas the company’s share price has increased by 60% per year.공고 • Jul 26Jubilant Industries Limited to Report Q1, 2023 Results on Aug 07, 2023Jubilant Industries Limited announced that they will report Q1, 2023 results on Aug 07, 2023Recent Insider Transactions • Jun 28CEO, MD & Whole-Time Director recently bought ₹3.0m worth of stockOn the 23rd of June, Manu Ahuja bought around 6k shares on-market at roughly ₹544 per share. This transaction amounted to 6.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Manu's only on-market trade for the last 12 months.New Risk • Jun 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (8.5% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change).Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹574, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 414% over the past three years.공고 • May 27Jubilant Industries Limited Appoints Mr. Abhishek Kamra as Company Secretary and Compliance OfficerJubilant Industries Limited announced that the Board of Directors of the Company have appointed Mr. Abhishek Kamra as Company Secretary and Compliance Officer of the Company at their meeting held on May 25, 2023 i.e. May25, 2023 with immediate effect. Mr. Abhishek Kamra, is a member of Institute of Company Secretaries of India (ICSI) and a Commerce Graduate. He carries approx. 7 years of work experience and specialized in the area of Securities & Capital Market Law, Corporate Laws, FEMA, Compliance Management, Stakeholders Management, Board Management, Merger & Acquisitions and ESOP.Reported Earnings • May 26Full year 2023 earnings released: EPS: ₹35.05 (vs ₹36.34 in FY 2022)Full year 2023 results: EPS: ₹35.05 (down from ₹36.34 in FY 2022). Revenue: ₹14.8b (up 27% from FY 2022). Net income: ₹527.9m (down 3.3% from FY 2022). Profit margin: 3.6% (down from 4.7% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has increased by 70% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Feb 05Third quarter 2023 earnings released: EPS: ₹4.42 (vs ₹3.49 in 3Q 2022)Third quarter 2023 results: EPS: ₹4.42 (up from ₹3.49 in 3Q 2022). Revenue: ₹3.48b (up 17% from 3Q 2022). Net income: ₹66.6m (up 27% from 3Q 2022). Profit margin: 1.9% (up from 1.8% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 06Second quarter 2023 earnings released: EPS: ₹9.75 (vs ₹19.08 in 2Q 2022)Second quarter 2023 results: EPS: ₹9.75 (down from ₹19.08 in 2Q 2022). Revenue: ₹4.27b (up 30% from 2Q 2022). Net income: ₹146.9m (down 49% from 2Q 2022). Profit margin: 3.4% (down from 8.8% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.공고 • Aug 31+ 3 more updatesJubilant Industries Limited to Report Fiscal Year 2023 Results on May 18, 2023Jubilant Industries Limited announced that they will report fiscal year 2023 results on May 18, 2023Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹497, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 408% over the past three years.공고 • Aug 07Jubilant Industries Limited to Report Q1, 2023 Results on Aug 12, 2022Jubilant Industries Limited announced that they will report Q1, 2023 results on Aug 12, 2022Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹441, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 398% over the past three years.Recent Insider Transactions • Jun 26CEO, MD & Whole-Time Director recently bought ₹2.5m worth of stockOn the 22nd of June, Manu Ahuja bought around 7k shares on-market at roughly ₹363 per share. This was the largest purchase by an insider in the last 3 months. This was Manu's only on-market trade for the last 12 months.Reported Earnings • May 29Full year 2022 earnings released: EPS: ₹36.34 (vs ₹5.70 loss in FY 2021)Full year 2022 results: EPS: ₹36.34 (up from ₹5.70 loss in FY 2021). Revenue: ₹11.7b (up 88% from FY 2021). Net income: ₹546.1m (up ₹631.8m from FY 2021). Profit margin: 4.7% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year whereas the company’s share price has increased by 52% per year.공고 • May 21Jubilant Industries Limited to Report Q4, 2022 Results on May 27, 2022Jubilant Industries Limited announced that they will report Q4, 2022 results on May 27, 2022Valuation Update With 7 Day Price Move • Feb 10Investor sentiment deteriorated over the past weekAfter last week's 27% share price decline to ₹518, the stock trades at a trailing P/E ratio of 27.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 378% over the past three years.Reported Earnings • Feb 05Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹3.49 (down from ₹5.33 in 3Q 2021). Revenue: ₹2.98b (up 89% from 3Q 2021). Net income: ₹52.4m (down 35% from 3Q 2021). Profit margin: 1.8% (down from 5.1% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has increased by 80% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 25% share price gain to ₹643, the stock trades at a trailing P/E ratio of 31.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 544% over the past three years.Valuation Update With 7 Day Price Move • Oct 28Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹575, the stock trades at a trailing P/E ratio of 28.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 431% over the past three years.Reported Earnings • Oct 22Second quarter 2022 earnings released: EPS ₹19.08 (vs ₹9.14 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹3.28b (up 88% from 2Q 2021). Net income: ₹286.8m (up 109% from 2Q 2021). Profit margin: 8.8% (up from 7.9% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has increased by 73% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Aug 12Investor sentiment improved over the past weekAfter last week's 44% share price gain to ₹568, the stock trades at a trailing P/E ratio of 53.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 308% over the past three years.Reported Earnings • Aug 09First quarter 2022 earnings released: EPS ₹14.54 (vs ₹1.81 loss in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹2.12b (up 125% from 1Q 2021). Net income: ₹218.5m (up ₹245.7m from 1Q 2021). Profit margin: 10% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year whereas the company’s share price has increased by 50% per year.Recent Insider Transactions • Jun 25CEO, MD & Whole-Time Director recently bought ₹4.8m worth of stockOn the 21st of June, Manu Ahuja bought around 15k shares on-market at roughly ₹317 per share. This was the largest purchase by an insider in the last 3 months. This was Manu's only on-market trade for the last 12 months.Reported Earnings • Jun 20Full year 2021 earnings released: ₹5.70 loss per share (vs ₹12.47 profit in FY 2020)The company reported a soft full year result with weaker earnings and weaker control over costs, although revenues improved. Full year 2021 results: Revenue: ₹6.24b (up 15% from FY 2020). Net loss: ₹85.6m (down 150% from profit in FY 2020). Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Apr 24Investor sentiment improved over the past weekAfter last week's 29% share price gain to ₹258, the stock trades at a trailing P/E ratio of 25.4x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 49% over the past three years.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹224, the stock trades at a trailing P/E ratio of 22.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 18% over the past three years.Is New 90 Day High Low • Mar 02New 90-day low: ₹210The company is down 16% from its price of ₹251 on 02 December 2020. The Indian market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.Reported Earnings • Feb 05Third quarter 2021 earnings released: EPS ₹5.33 (vs ₹2.81 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹1.58b (up 23% from 3Q 2020). Net income: ₹80.0m (up 107% from 3Q 2020). Profit margin: 5.1% (up from 3.0% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹256, the stock is trading at a trailing P/E ratio of 29.2x, up from the previous P/E ratio of 25.4x. This compares to an average P/E of 18x in the Chemicals industry in India. Total returns to shareholders over the past three years are 22%.공고 • Jan 29Jubilant Industries Limited to Report Q3, 2021 Results on Feb 04, 2021Jubilant Industries Limited announced that they will report Q3, 2021 results on Feb 04, 2021Is New 90 Day High Low • Jan 05New 90-day high: ₹260The company is up 78% from its price of ₹146 on 07 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period.Valuation Update With 7 Day Price Move • Dec 02Market bids up stock over the past weekAfter last week's 20% share price gain to ₹251, the stock is trading at a trailing P/E ratio of 28.7x, up from the previous P/E ratio of 24x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 6.1%.Valuation Update With 7 Day Price Move • Nov 26Market bids up stock over the past weekAfter last week's 19% share price gain to ₹215, the stock is trading at a trailing P/E ratio of 24.6x, up from the previous P/E ratio of 20.7x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years were flat.Reported Earnings • Nov 18Second quarter 2021 earnings released: EPS ₹9.14The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹1.74b (up 25% from 2Q 2020). Net income: ₹137.4m (up 144% from 2Q 2020). Profit margin: 7.9% (up from 4.1% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Is New 90 Day High Low • Nov 12New 90-day high: ₹178The company is up 9.0% from its price of ₹163 on 14 August 2020. The Indian market is also up 9.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 11% over the same period.Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 21% share price gain to ₹157, the stock is trading at a trailing P/E ratio of 12.6x, up from the previous P/E ratio of 10.4x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 28%.공고 • Nov 07Jubilant Industries Limited Announces Resignation of Sushil Kumar Roongta from the Position of Non-Executive Independent DirectorJubilant Industries Limited announced resignation of Sushil Kumar Roongta from the position of Non-Executive Independent Director of the company with effect from conclusion of the meeting of the Board of Directors held on November 6, 2020.공고 • Oct 31Jubilant Industries Limited to Report Q2, 2021 Results on Nov 06, 2020Jubilant Industries Limited announced that they will report Q2, 2021 results on Nov 06, 2020공고 • Aug 28Jubilant Industries Limited to Report Q1, 2021 Results on Sep 03, 2020Jubilant Industries Limited announced that they will report Q1, 2021 results on Sep 03, 2020공고 • Jul 24Jubilant Industries Limited Announces Impact of the Covid-19 Pandemic on the BusinessJubilant Industries Limited announced that due to COVID-19 outbreak and as per directives issued by the Government of India, State Governments and other regulatory authorities, the company had temporarily suspended manufacturing in some of Plants. Operations were partially resumed and full resumption is expected in next couple of months. The Company has also Implemented "Work from Home" Policy for its employees to ensure compliance with Government's directives and to safeguard employee's health and safety.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 533320 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 533320 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Jubilant Industries 배당 수익률 vs 시장533320의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (533320)n/a시장 하위 25% (IN)0.3%시장 상위 25% (IN)1.4%업계 평균 (Chemicals)0.8%분석가 예측 (533320) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 533320 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 533320 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 533320 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 533320 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2025/01/22 05:30종가2024/10/25 00:00수익2024/06/30연간 수익2024/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Jubilant Industries Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공고 • Oct 03Jubilant Industries Limited Announces Resignation of Brijesh Kumar as Company Secretary & Compliance Officer, Effective November 13, 2024Jubilant Industries Limited announced that the Mr. Brijesh Kumar, Company Secretary & Compliance Officer of the Company has submitted resignation to pursue opportunity outside the organisation. The management has accepted his resignation and accordingly he shall be relieved from his responsibilities on November 13, 2024. Further, Mr. Brijesh Kumar has also tendered his resignation from the post of Company Secretary from wholly owned subsidiary of the Company Jubilant Agri and Consumer Products Limited November 13, 2024. The management has accepted his resignation and accordingly he shall be relieved from his responsibilities w.e.f November 13, 2024.
공고 • Aug 30Jubilant Industries Limited, Annual General Meeting, Sep 23, 2024Jubilant Industries Limited, Annual General Meeting, Sep 23, 2024, at 15:00 Indian Standard Time.
공고 • Aug 29+ 2 more updatesJubilant Industries Limited to Report Fiscal Year 2025 Results on May 15, 2025Jubilant Industries Limited announced that they will report fiscal year 2025 results on May 15, 2025
Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: ₹17.31 (vs ₹13.84 in 1Q 2024)First quarter 2025 results: EPS: ₹17.31 (up from ₹13.84 in 1Q 2024). Revenue: ₹3.59b (up 3.0% from 1Q 2024). Net income: ₹260.8m (up 25% from 1Q 2024). Profit margin: 7.3% (up from 6.0% in 1Q 2024). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 42% per year, which means it is tracking significantly ahead of earnings growth.
공고 • Aug 01Jubilant Industries Limited to Report Q1, 2025 Results on Aug 12, 2024Jubilant Industries Limited announced that they will report Q1, 2025 results on Aug 12, 2024
Buy Or Sell Opportunity • Jul 05Now 20% undervaluedOver the last 90 days, the stock has risen 23% to ₹1,592. The fair value is estimated to be ₹1,998, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Meanwhile, the company has become profitable.
공고 • Jun 27Jubilant Industries Limited and Jubilant Agri and Consumer Products Limited Announces Resignation of Jagat Sharma from the Post of Director and Whole Time DirectorJubilant Industries Limited at its board meeting held on June 27, 2024 Noted the resignation of Mr. Jagat Sharma from the post of Director and Whole Time Director of the Company with effect from the close of business hours on June 26, 2024, citing personal reasons. However, he will continue in the employment of the Company. Mr. Sharma has also resigned as Director and Whole Time Director of Jubilant Agri and Consumer Products Limited ("Wholly Owned Subsidiary" of the Company) with effect from the close of business hours on June 26, 2024. However, he will continue as an employee of JACPL.
Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹1,286, the stock trades at a trailing P/E ratio of 66.1x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 310% over the past three years.
Reported Earnings • May 29Full year 2024 earnings released: EPS: ₹19.37 (vs ₹35.06 in FY 2023)Full year 2024 results: EPS: ₹19.37 (down from ₹35.06 in FY 2023). Revenue: ₹12.5b (down 15% from FY 2023). Net income: ₹292.0m (down 45% from FY 2023). Profit margin: 2.3% (down from 3.6% in FY 2023). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 59% per year, which means it is tracking significantly ahead of earnings growth.
공고 • May 17Jubilant Industries Limited to Report Q4, 2024 Results on May 27, 2024Jubilant Industries Limited announced that they will report Q4, 2024 results on May 27, 2024
Buy Or Sell Opportunity • May 16Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 19% to ₹1,110. The fair value is estimated to be ₹917, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 32%.
Board Change • Apr 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Sanjanthi Sajan was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Buy Or Sell Opportunity • Feb 21Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 64% to ₹1,122. The fair value is estimated to be ₹931, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 32%.
공고 • Feb 19Jubilant Industries Limited Appoints Jagat Sharma as A Whole-Time DirectorJubilant Industries Limited appointed Jagat Sharma as a Whole-time Director.
New Risk • Feb 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (73% net debt to equity). Share price has been volatile over the past 3 months (8.6% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin).
New Risk • Feb 13New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 65% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (64% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin).
Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹722, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 230% over the past three years.
공고 • Jan 30Jubilant Industries Limited to Report Q3, 2024 Results on Feb 09, 2024Jubilant Industries Limited announced that they will report Q3, 2024 results on Feb 09, 2024
Reported Earnings • Nov 07Second quarter 2024 earnings released: EPS: ₹6.00 (vs ₹9.75 in 2Q 2023)Second quarter 2024 results: EPS: ₹6.00 (down from ₹9.75 in 2Q 2023). Revenue: ₹3.12b (down 27% from 2Q 2023). Net income: ₹90.4m (down 39% from 2Q 2023). Profit margin: 2.9% (down from 3.4% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 47% per year whereas the company’s share price has increased by 49% per year.
New Risk • Nov 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.5% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (7.6% average weekly change).
New Risk • Oct 30New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.29b (US$99.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.5% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (₹8.29b market cap, or US$99.6m).
공고 • Oct 28Jubilant Industries Limited to Report Q2, 2024 Results on Nov 06, 2023Jubilant Industries Limited announced that they will report Q2, 2024 results on Nov 06, 2023
Board Change • Oct 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Ravinder Sharma was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공고 • Aug 27Jubilant Industries Limited, Annual General Meeting, Sep 21, 2023Jubilant Industries Limited, Annual General Meeting, Sep 21, 2023, at 15:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Aug 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹625, the stock trades at a trailing P/E ratio of 18.2x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 280% over the past three years.
공고 • Aug 08Jubilant Industries Limited Appoints Brijesh Kumar as Company Secretary and Compliance OfficerThe Board of Directors of Jubilant Industries Limited at its meeting held on August 7, 2023 at 3:00 P.M. (concluded at 5:00 P.M.), had on the recommendations of the Nomination Remuneration and Compensation Committee approved the appointment of Mr. Brijesh Kumar as the Company Secretary and Compliance Officer of the company with immediate effect. Consequent to the said appointment, Mr. Abhishek Kamra (ICSI Membership No.: A48236) who was appointed on interim basis, will step down from the position of Company Secretary and Compliance Officer of the Company with immediate effect. Date of Appointment and Terms of Appointment: Date of Appointment is August 7, 2023 and terms of appointment shall be as per the companies HR Policy. Brief Profile: Mr. Brijesh Kumar is a member of the Institute of Company Secretaries of India, a graduate in Law and holds Bachelor's degree in Commerce - B.Com (Hons) with over 11 years of experience in the area of corporate secretarial and legal affairs of the Company. He has good experience in Securities and Capital Market Laws, Corporate Laws, FEMA and Compliance Management and has handled Merger and Acquisitions, Listing of shares, Fund Raising, ESOP, joint ventures etc. He was previously associated with Uno Minda Limited and AKM Global in the past.
Reported Earnings • Aug 08First quarter 2024 earnings released: EPS: ₹13.84 (vs ₹14.43 in 1Q 2023)First quarter 2024 results: EPS: ₹13.84 (down from ₹14.43 in 1Q 2023). Revenue: ₹3.49b (down 1.6% from 1Q 2023). Net income: ₹208.6m (down 3.9% from 1Q 2023). Profit margin: 6.0% (down from 6.1% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 58% per year whereas the company’s share price has increased by 60% per year.
공고 • Jul 26Jubilant Industries Limited to Report Q1, 2023 Results on Aug 07, 2023Jubilant Industries Limited announced that they will report Q1, 2023 results on Aug 07, 2023
Recent Insider Transactions • Jun 28CEO, MD & Whole-Time Director recently bought ₹3.0m worth of stockOn the 23rd of June, Manu Ahuja bought around 6k shares on-market at roughly ₹544 per share. This transaction amounted to 6.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Manu's only on-market trade for the last 12 months.
New Risk • Jun 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (8.5% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change).
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹574, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 414% over the past three years.
공고 • May 27Jubilant Industries Limited Appoints Mr. Abhishek Kamra as Company Secretary and Compliance OfficerJubilant Industries Limited announced that the Board of Directors of the Company have appointed Mr. Abhishek Kamra as Company Secretary and Compliance Officer of the Company at their meeting held on May 25, 2023 i.e. May25, 2023 with immediate effect. Mr. Abhishek Kamra, is a member of Institute of Company Secretaries of India (ICSI) and a Commerce Graduate. He carries approx. 7 years of work experience and specialized in the area of Securities & Capital Market Law, Corporate Laws, FEMA, Compliance Management, Stakeholders Management, Board Management, Merger & Acquisitions and ESOP.
Reported Earnings • May 26Full year 2023 earnings released: EPS: ₹35.05 (vs ₹36.34 in FY 2022)Full year 2023 results: EPS: ₹35.05 (down from ₹36.34 in FY 2022). Revenue: ₹14.8b (up 27% from FY 2022). Net income: ₹527.9m (down 3.3% from FY 2022). Profit margin: 3.6% (down from 4.7% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has increased by 70% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Feb 05Third quarter 2023 earnings released: EPS: ₹4.42 (vs ₹3.49 in 3Q 2022)Third quarter 2023 results: EPS: ₹4.42 (up from ₹3.49 in 3Q 2022). Revenue: ₹3.48b (up 17% from 3Q 2022). Net income: ₹66.6m (up 27% from 3Q 2022). Profit margin: 1.9% (up from 1.8% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 06Second quarter 2023 earnings released: EPS: ₹9.75 (vs ₹19.08 in 2Q 2022)Second quarter 2023 results: EPS: ₹9.75 (down from ₹19.08 in 2Q 2022). Revenue: ₹4.27b (up 30% from 2Q 2022). Net income: ₹146.9m (down 49% from 2Q 2022). Profit margin: 3.4% (down from 8.8% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth.
공고 • Aug 31+ 3 more updatesJubilant Industries Limited to Report Fiscal Year 2023 Results on May 18, 2023Jubilant Industries Limited announced that they will report fiscal year 2023 results on May 18, 2023
Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹497, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 408% over the past three years.
공고 • Aug 07Jubilant Industries Limited to Report Q1, 2023 Results on Aug 12, 2022Jubilant Industries Limited announced that they will report Q1, 2023 results on Aug 12, 2022
Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹441, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 398% over the past three years.
Recent Insider Transactions • Jun 26CEO, MD & Whole-Time Director recently bought ₹2.5m worth of stockOn the 22nd of June, Manu Ahuja bought around 7k shares on-market at roughly ₹363 per share. This was the largest purchase by an insider in the last 3 months. This was Manu's only on-market trade for the last 12 months.
Reported Earnings • May 29Full year 2022 earnings released: EPS: ₹36.34 (vs ₹5.70 loss in FY 2021)Full year 2022 results: EPS: ₹36.34 (up from ₹5.70 loss in FY 2021). Revenue: ₹11.7b (up 88% from FY 2021). Net income: ₹546.1m (up ₹631.8m from FY 2021). Profit margin: 4.7% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year whereas the company’s share price has increased by 52% per year.
공고 • May 21Jubilant Industries Limited to Report Q4, 2022 Results on May 27, 2022Jubilant Industries Limited announced that they will report Q4, 2022 results on May 27, 2022
Valuation Update With 7 Day Price Move • Feb 10Investor sentiment deteriorated over the past weekAfter last week's 27% share price decline to ₹518, the stock trades at a trailing P/E ratio of 27.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 378% over the past three years.
Reported Earnings • Feb 05Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹3.49 (down from ₹5.33 in 3Q 2021). Revenue: ₹2.98b (up 89% from 3Q 2021). Net income: ₹52.4m (down 35% from 3Q 2021). Profit margin: 1.8% (down from 5.1% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has increased by 80% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 25% share price gain to ₹643, the stock trades at a trailing P/E ratio of 31.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 544% over the past three years.
Valuation Update With 7 Day Price Move • Oct 28Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹575, the stock trades at a trailing P/E ratio of 28.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 431% over the past three years.
Reported Earnings • Oct 22Second quarter 2022 earnings released: EPS ₹19.08 (vs ₹9.14 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹3.28b (up 88% from 2Q 2021). Net income: ₹286.8m (up 109% from 2Q 2021). Profit margin: 8.8% (up from 7.9% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has increased by 73% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Aug 12Investor sentiment improved over the past weekAfter last week's 44% share price gain to ₹568, the stock trades at a trailing P/E ratio of 53.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 308% over the past three years.
Reported Earnings • Aug 09First quarter 2022 earnings released: EPS ₹14.54 (vs ₹1.81 loss in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹2.12b (up 125% from 1Q 2021). Net income: ₹218.5m (up ₹245.7m from 1Q 2021). Profit margin: 10% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year whereas the company’s share price has increased by 50% per year.
Recent Insider Transactions • Jun 25CEO, MD & Whole-Time Director recently bought ₹4.8m worth of stockOn the 21st of June, Manu Ahuja bought around 15k shares on-market at roughly ₹317 per share. This was the largest purchase by an insider in the last 3 months. This was Manu's only on-market trade for the last 12 months.
Reported Earnings • Jun 20Full year 2021 earnings released: ₹5.70 loss per share (vs ₹12.47 profit in FY 2020)The company reported a soft full year result with weaker earnings and weaker control over costs, although revenues improved. Full year 2021 results: Revenue: ₹6.24b (up 15% from FY 2020). Net loss: ₹85.6m (down 150% from profit in FY 2020). Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Apr 24Investor sentiment improved over the past weekAfter last week's 29% share price gain to ₹258, the stock trades at a trailing P/E ratio of 25.4x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 49% over the past three years.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹224, the stock trades at a trailing P/E ratio of 22.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 18% over the past three years.
Is New 90 Day High Low • Mar 02New 90-day low: ₹210The company is down 16% from its price of ₹251 on 02 December 2020. The Indian market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.
Reported Earnings • Feb 05Third quarter 2021 earnings released: EPS ₹5.33 (vs ₹2.81 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹1.58b (up 23% from 3Q 2020). Net income: ₹80.0m (up 107% from 3Q 2020). Profit margin: 5.1% (up from 3.0% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹256, the stock is trading at a trailing P/E ratio of 29.2x, up from the previous P/E ratio of 25.4x. This compares to an average P/E of 18x in the Chemicals industry in India. Total returns to shareholders over the past three years are 22%.
공고 • Jan 29Jubilant Industries Limited to Report Q3, 2021 Results on Feb 04, 2021Jubilant Industries Limited announced that they will report Q3, 2021 results on Feb 04, 2021
Is New 90 Day High Low • Jan 05New 90-day high: ₹260The company is up 78% from its price of ₹146 on 07 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period.
Valuation Update With 7 Day Price Move • Dec 02Market bids up stock over the past weekAfter last week's 20% share price gain to ₹251, the stock is trading at a trailing P/E ratio of 28.7x, up from the previous P/E ratio of 24x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 6.1%.
Valuation Update With 7 Day Price Move • Nov 26Market bids up stock over the past weekAfter last week's 19% share price gain to ₹215, the stock is trading at a trailing P/E ratio of 24.6x, up from the previous P/E ratio of 20.7x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years were flat.
Reported Earnings • Nov 18Second quarter 2021 earnings released: EPS ₹9.14The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹1.74b (up 25% from 2Q 2020). Net income: ₹137.4m (up 144% from 2Q 2020). Profit margin: 7.9% (up from 4.1% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Is New 90 Day High Low • Nov 12New 90-day high: ₹178The company is up 9.0% from its price of ₹163 on 14 August 2020. The Indian market is also up 9.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 11% over the same period.
Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 21% share price gain to ₹157, the stock is trading at a trailing P/E ratio of 12.6x, up from the previous P/E ratio of 10.4x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 28%.
공고 • Nov 07Jubilant Industries Limited Announces Resignation of Sushil Kumar Roongta from the Position of Non-Executive Independent DirectorJubilant Industries Limited announced resignation of Sushil Kumar Roongta from the position of Non-Executive Independent Director of the company with effect from conclusion of the meeting of the Board of Directors held on November 6, 2020.
공고 • Oct 31Jubilant Industries Limited to Report Q2, 2021 Results on Nov 06, 2020Jubilant Industries Limited announced that they will report Q2, 2021 results on Nov 06, 2020
공고 • Aug 28Jubilant Industries Limited to Report Q1, 2021 Results on Sep 03, 2020Jubilant Industries Limited announced that they will report Q1, 2021 results on Sep 03, 2020
공고 • Jul 24Jubilant Industries Limited Announces Impact of the Covid-19 Pandemic on the BusinessJubilant Industries Limited announced that due to COVID-19 outbreak and as per directives issued by the Government of India, State Governments and other regulatory authorities, the company had temporarily suspended manufacturing in some of Plants. Operations were partially resumed and full resumption is expected in next couple of months. The Company has also Implemented "Work from Home" Policy for its employees to ensure compliance with Government's directives and to safeguard employee's health and safety.